Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Quantifying the effects of promoting smokeless tobacco as a harm reduction strategy in the USA.

Mejia AB, Ling PM, Glantz SA.

Tob Control. 2010 Aug;19(4):297-305. doi: 10.1136/tc.2009.031427. Epub 2010 Jun 27.

2.

The complexity of 'harm reduction' with smokeless tobacco as an approach to tobacco control in low-income and middle-income countries.

Ayo-Yusuf OA, Burns DM.

Tob Control. 2012 Mar;21(2):245-51. doi: 10.1136/tobaccocontrol-2011-050367. Review.

PMID:
22345261
3.

Smokeless tobacco: a gateway to smoking or a way away from smoking.

Melikian AA, Hoffmann D.

Biomarkers. 2009 Jul;14 Suppl 1:85-9. doi: 10.1080/13547500902965401. Review.

PMID:
19604066
4.
5.

[Harm reduction strategy in tobacco control].

Gorini G.

Epidemiol Prev. 2011 May-Aug;35(3-4 Suppl 1):19-32. Review. Italian.

6.

Does dual use jeopardize the potential role of smokeless tobacco in harm reduction?

Frost-Pineda K, Appleton S, Fisher M, Fox K, Gaworski CL.

Nicotine Tob Res. 2010 Nov;12(11):1055-67. doi: 10.1093/ntr/ntq147. Epub 2010 Sep 16. Review.

PMID:
20847148
7.

Tobacco, nicotine and harm reduction.

Le Houezec J, McNeill A, Britton J.

Drug Alcohol Rev. 2011 Mar;30(2):119-23. doi: 10.1111/j.1465-3362.2010.00264.x. Review.

PMID:
21375611
8.

Review of epidemiologic data on the debate over smokeless tobacco's role in harm reduction.

Timberlake DS, Zell JA.

BMC Med. 2009 Oct 19;7:61. doi: 10.1186/1741-7015-7-61. Review.

9.

Epidemiologic perspectives on smokeless tobacco marketing and population harm.

Tomar SL.

Am J Prev Med. 2007 Dec;33(6 Suppl):S387-97. Review.

PMID:
18021914
10.

A fresh look at tobacco harm reduction: the case for the electronic cigarette.

Polosa R, Rodu B, Caponnetto P, Maglia M, Raciti C.

Harm Reduct J. 2013 Oct 4;10:19. doi: 10.1186/1477-7517-10-19. Review.

11.

Is smokeless tobacco use an appropriate public health strategy for reducing societal harm from cigarette smoking?

Tomar SL, Fox BJ, Severson HH.

Int J Environ Res Public Health. 2009 Jan;6(1):10-24. doi: 10.3390/ijerph6010010. Epub 2008 Dec 23. Review.

12.

Smokeless tobacco use: harm reduction or induction approach?

Hatsukami DK, Lemmonds C, Tomar SL.

Prev Med. 2004 Mar;38(3):309-17. Review.

PMID:
14766113
13.

The Strategic Dialogue on Tobacco Harm Reduction: a vision and blueprint for action in the US.

Zeller M, Hatsukami D; Strategic Dialogue on Tobacco Harm Reduction Group.

Tob Control. 2009 Aug;18(4):324-32. doi: 10.1136/tc.2008.027318. Epub 2009 Feb 24.

PMID:
19240228
14.

Health risks related to dual use of cigarettes and snus - a systematic review.

Lee PN.

Regul Toxicol Pharmacol. 2014 Jun;69(1):125-34. doi: 10.1016/j.yrtph.2013.10.007. Epub 2013 Oct 31. Review.

15.

[Extreme solutions for those who do not succeed to quit smoking. About smokeless tobacco and harm reduction].

Trofor A, Eşanu V, Frăsilă EI.

Pneumologia. 2008 Apr-Jun;57(2):105-8. Review. Romanian.

PMID:
18822878
16.

An epidemiologic review of smokeless tobacco health effects and harm reduction potential.

Colilla SA.

Regul Toxicol Pharmacol. 2010 Mar;56(2):197-211. doi: 10.1016/j.yrtph.2009.09.017. Epub 2009 Sep 29. Review.

PMID:
19796662
17.

Smokeless tobacco: the epidemiology and politics of harm.

Phillips CV, Heavner KK.

Biomarkers. 2009 Jul;14 Suppl 1:79-84. doi: 10.1080/13547500902965476. Review.

PMID:
19604065
18.

Snuffing out cigarette sales and the smoking deaths epidemic.

Laugesen M.

N Z Med J. 2007 Jun 15;120(1256):U2587. Review.

PMID:
17589555
19.

Developing smokeless tobacco products for smokers: an examination of tobacco industry documents.

Carpenter CM, Connolly GN, Ayo-Yusuf OA, Wayne GF.

Tob Control. 2009 Feb;18(1):54-9. doi: 10.1136/tc.2008.026583. Epub 2008 Oct 23. Review.

20.

Tobacco smoking, harm reduction, and biomarkers.

Shields PG.

J Natl Cancer Inst. 2002 Oct 2;94(19):1435-44. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk